Orchid Pharma Ltd. | Balance Sheet

Fiscal year is April-March. All values INR Millions.
2013
2015
2016
2017
2018
Cash & Short Term Investments
234
3,906
3,149
2,571
3,056
Total Accounts Receivable
1,798
3,619
4,155
2,033
1,195
Inventories
8,555
6,002
5,816
5,318
1,937
Other Current Assets
426
745
608
1,131
601
Total Current Assets
11,014
12,781
12,512
8,791
6,789
Net Property, Plant & Equipment
32,531
19,305
23,238
21,958
15,255
Total Investments and Advances
39
26
15
29
208
Intangible Assets
1,675
1,462
1,393
1,348
1,322
Other Assets
1,251
7,040
1,462
1,453
7,679
Total Assets
47,061
40,614
38,621
33,580
31,254
ST Debt & Current Portion LT Debt
25,167
7,167
8,378
9,494
6,943
Accounts Payable
5,974
3,112
3,734
4,245
3,588
Income Tax Payable
39
-
-
-
-
Other Current Liabilities
880
948
1,264
1,668
9,594
Total Current Liabilities
32,060
11,227
13,376
15,407
20,125
Long-Term Debt
9,018
24,940
23,775
21,568
18,939
Provision for Risks & Charges
52
42
37
21
75
Deferred Taxes
1,574
1,112
941
461
32
Total Liabilities
43,255
37,320
38,130
37,457
39,171
Common Equity (Total)
3,800
3,294
490
3,877
7,918
Total Shareholders' Equity
3,800
3,294
490
3,877
7,918
Total Equity
3,806
3,294
490
3,877
7,918
Liabilities & Shareholders' Equity
47,061
40,614
38,621
33,580
31,254
Accumulated Minority Interest
6
-
-
-
-

About Orchid Pharma

View Profile
Address
Orchid Towers
Chennai Tamil Nadu 600034
India
Employees -
Website http://www.orchidpharma.com
Updated 09/14/2018
Orchid Pharma Ltd. engages in the development, manufacture, and marketing of diverse bulk actives, formulations, and nutraceuticals. Its products include cardiovascular, anti-diabetic, neuropsychiatry, nutritional supplements, cephalosporins-orals, cephalosporins-injectibles, veterinary products, and non-antibiotics. The company was founded by by Kailasam Raghavendra Rao on July 1, 1992 and is headquartered in Chennai, India.